{"schema_version":"1","generated_at":"2026-10-28T22:21:35.877Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kamnesh-pradhan","json_url":"https://www.findmykol.com/kol/kamnesh-pradhan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kamnesh-pradhan","name":"Kamnesh Pradhan","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Eli Lilly","institution_url":"https://www.findmykol.com/institution/eli-lilly","city":"Indianapolis","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1295828184","orcid":"0000-0002-1488-5992","openalex":"A5039247981"},"summary":"Kamnesh Pradhan is an Oncology physician affiliated with Eli Lilly. OpenAlex indexes 35 publications with 1,419 citations (h-index 16).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":35,"cited_by_count":1419,"h_index":16,"latest_activity_year":2025,"source":"works"},"publications":{"total":39,"shown":5,"withheld":34,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract GS1-01: Imlunestrant, an Oral Selective Estrogen Receptor Degrader (SERD), as Monotherapy & Combined with Abemaciclib, for Patients with ER+, HER2- Advanced Breast Cancer (ABC), Pretreated with Endocrine Therapy (ET): Results of the Phase 3 EMBER-3 trial","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-gs1-01","status":"verified"},{"title":"Ramucirumab in pediatric and young adult patients (Pts) with relapsed/refractory (R/R) desmoplastic small round cell tumor (DSRCT) or synovial sarcoma (SS): Results from the CAMPFIRE study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.11574","status":"verified"},{"title":"306P Imlunestrant with or without abemaciclib as first- and second-line therapy in advanced breast cancer (ABC): A subgroup analysis from the EMBER-3 trial","year":2025,"journal":"ESMO Open","source_url":"https://doi.org/10.1016/j.esmoop.2025.104878","status":"verified"},{"title":"Imlunestrant with or without Abemaciclib in Advanced Breast Cancer","year":2024,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2410858","status":"verified"},{"title":"A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors","year":2024,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.30817","status":"verified"}],"source":"works"},"similar":[{"name":"Mark Bangs","slug":"mark-bangs","institution":"Eli Lilly","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/mark-bangs","json_url":"https://www.findmykol.com/kol/mark-bangs/profile.json"},{"name":"David Alan Cox","slug":"david-cox-us","institution":"Eli Lilly","url":"https://www.findmykol.com/kol/david-cox-us","json_url":"https://www.findmykol.com/kol/david-cox-us/profile.json"},{"name":"Heidi Crane","slug":"heidi-crane","institution":"Eli Lilly","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/heidi-crane","json_url":"https://www.findmykol.com/kol/heidi-crane/profile.json"},{"name":"Mike Hutton","slug":"mike-hutton","institution":"Eli Lilly","url":"https://www.findmykol.com/kol/mike-hutton","json_url":"https://www.findmykol.com/kol/mike-hutton/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":34}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}